ATE432349T1 - Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung - Google Patents

Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung

Info

Publication number
ATE432349T1
ATE432349T1 AT96919450T AT96919450T ATE432349T1 AT E432349 T1 ATE432349 T1 AT E432349T1 AT 96919450 T AT96919450 T AT 96919450T AT 96919450 T AT96919450 T AT 96919450T AT E432349 T1 ATE432349 T1 AT E432349T1
Authority
AT
Austria
Prior art keywords
hemoglobin
compounds
methods
proteins
purification
Prior art date
Application number
AT96919450T
Other languages
English (en)
Inventor
Stephen P Trimble
David C Anderson
Antony J Mathews
Spencer Anthony-Cahill
David A Marquardt
Dominic G Madril
Bruce A Kerwin
Janet K Epp
Original Assignee
Baxter Biotech Tech Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Biotech Tech Sarl filed Critical Baxter Biotech Tech Sarl
Application granted granted Critical
Publication of ATE432349T1 publication Critical patent/ATE432349T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
AT96919450T 1995-06-07 1996-06-06 Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung ATE432349T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/487,431 US5844090A (en) 1994-05-09 1995-06-07 Modified hemoglobin-like compounds
PCT/US1996/010420 WO1996040920A1 (en) 1992-11-06 1996-06-06 Modified hemoglobin-like compounds and methods of purifying same

Publications (1)

Publication Number Publication Date
ATE432349T1 true ATE432349T1 (de) 2009-06-15

Family

ID=23935700

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919450T ATE432349T1 (de) 1995-06-07 1996-06-06 Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung

Country Status (8)

Country Link
US (1) US5844090A (de)
EP (1) EP0832228B1 (de)
JP (2) JPH11507388A (de)
AT (1) ATE432349T1 (de)
AU (1) AU714185B2 (de)
CA (1) CA2219242A1 (de)
DE (1) DE69637941D1 (de)
WO (1) WO1996040920A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150506A (en) * 1989-05-10 2000-11-21 Baxter Biotech Technology Sarl Modified hemoglobin-like compounds and methods of purifying same
WO1997023631A2 (en) * 1995-12-22 1997-07-03 Somatogen, Inc. Globins containing binding domains
AU6340998A (en) * 1997-02-28 1998-09-18 Somatogen, Inc. Permuted hemoglobin-like proteins
EP1950298A3 (de) 1997-05-02 2008-12-24 Baxter Biotech Technology S.A.R.L. Hämoglobinmutanten mit erhöhtem Löslichkeitswert und/oder reduzierter Stickoxidspülung
WO1998050430A2 (en) 1997-05-02 1998-11-12 Somatogen, Inc. Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
EP1098666B1 (de) * 1998-07-17 2013-01-16 The United States of America, represented by the Secretary, Department of Health and Human Services Wasserlösliche arzneimittel und deren herstellungsmethode
US6894150B1 (en) 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
EP1233986A4 (de) * 1999-11-12 2003-01-02 Baxter Biotech Tech Sarl Hämoglobin-zusammensetzungen mit verminderten nebeneffekten
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US7494974B2 (en) * 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
KR20250113486A (ko) * 2022-11-30 2025-07-25 강마-헬스코드 (상하이) 바이오테크 컴퍼니 리미티드 재조합 헤모글로빈

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
DE3144705C2 (de) * 1981-11-11 1983-12-08 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat
US4529719A (en) * 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4584130A (en) * 1985-03-29 1986-04-22 University Of Maryland Intramolecularly cross-linked hemoglobin and method of preparation
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
KR920701434A (ko) * 1989-05-10 1992-08-11 원본미기재 박테리아 및 이스트 내에서의 헤모글로빈 및 그의 동족체의 제조방법
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
US5599907A (en) * 1989-05-10 1997-02-04 Somatogen, Inc. Production and use of multimeric hemoglobins
CA2080589A1 (en) * 1990-04-16 1991-10-17 Joseph De Angelo Expression of recombinant hemoglobin in yeast
CA2098818A1 (en) * 1990-12-20 1992-06-21 Tim Townes Transgenic, cross-linked hemoglobin
US5665869A (en) * 1993-11-15 1997-09-09 Somatogen, Inc. Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin

Also Published As

Publication number Publication date
JP3991057B2 (ja) 2007-10-17
DE69637941D1 (de) 2009-07-09
CA2219242A1 (en) 1996-12-19
JP2006206592A (ja) 2006-08-10
US5844090A (en) 1998-12-01
WO1996040920A1 (en) 1996-12-19
JPH11507388A (ja) 1999-06-29
AU6179096A (en) 1996-12-30
AU714185B2 (en) 1999-12-23
EP0832228B1 (de) 2009-05-27
EP0832228A1 (de) 1998-04-01

Similar Documents

Publication Publication Date Title
ATE91684T1 (de) 1,2-cyclohexylaminoarylamide zu verwendung als analgetika.
DK1240337T3 (da) Fremgangsmåder og præparater til forlængelse af elimeneringshalveringstider af bioaktive forbindelser
DE3484691D1 (de) Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
LU91759I2 (fr) Denosumab et ses dérivés pharmaceutique acceptables (PROLIA®)
TR200001079T2 (tr) Bisiklik kinaz inhibitörleri.
ATE58534T1 (de) 2-pyrimidinyl-l-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DK0815114T3 (da) Nucleinsyresyntese ved anvendelse af lysfraspaltelige beskyttende grupper
UA27763C2 (uk) Рекомбінантна молекула днк, що кодує молекулу адгезії icam-3, молекула адгезії icam-3, антитіло, здатне зв'язуватись з такою молекулою, фармацевтична композиція
ATE87006T1 (de) Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung.
DE69637941D1 (de) Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE59010189D1 (de) Aminosäurederivate mit reninhemmenden Eigenschaften, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung
ATE303437T1 (de) Rezeptor des ob-proteins und verwandte zusammensetzungen und verfahren
ATE93863T1 (de) Enzym-hemmende aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung.
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
PT87537A (pt) Process for the preparation of cyclic anticoagulant peptides
DE3864636D1 (de) Amidverbindungen, verfahren zu ihrer herstellung und zusammensetzung zur aktivierung gastromotorischer funktionen.
DE59409456D1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
FI930626A0 (fi) Proteinstruktur hos vaexttoxingelonin
DK0552765T3 (da) benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling
JPS6416791A (en) Guanidine related compound containing substituted tetraphenylborate ion and its production
DE68902386D1 (de) N-pyridinyl-9h-carbazol-9-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
ATE281519T1 (de) Klonierung und rekombinante herstellung des crf- rezeptors (crf=corticotropin ausloese faktor)
DE69935785D1 (de) Substitutierte aminosaeuren als erythropoietin-mimetica
ATE73818T1 (de) Verfahren zur herstellung von peptiden unter der verwendung von perchloraten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties